As of 2026, the most frequently cited conditions in these legal actions include gastroparesis, cholecystitis (gallbladder inflammation), gallstones, and intestinal obstruction
Their remarkable efficacy in reducing both body weight and obesity-related comorbidities, including CVD and overall mortality ( Indeed, pharmacotherapy with GLP-1 receptor or dual GIP/GLP-1 receptor agonists in patients with obesity achieves impressive reductions in body weight in the range of 1525% compared with TRE or other nutritional interventions, which are typically in the range of 34% ( Indeed, although long-term monitoring of the adverse effects of anti-obesity medications is still needed, data from clinical trials supports favorable efficacy versus safety profiles and demonstrates significant improvements in several cardiometabolic health parameters ( A mixed strategy incorporating both pharmacotherapy and dietary interventions may offer the most comprehensive and pragmatic approach to obesity and cardiometabolic risk management
The brand's broader growth model is built around digital-first distribution and localized product positioning
A lighter body simply uses less energy to move, further reducing how many calories you burn
A systematic review and meta-analysis of 11 randomized controlled trials involving 840 women with PCOS concluded that GLP-1RAs significantly improve natural conception rates (RR: 1.72, 95% CI: 1.222.43
